Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Europe Readies For Big Changes In Device Postmarket Surveillance

This article was originally published in The Gray Sheet

Executive Summary

Europe may be on the cusp of a big drive toward a more clearly organized and more transparent postmarket vigilance system with new funds directed at the issue in the wake of device safety scandals. The European Commission recently launched the second phase of its joint action plan of near-term device and diagnostics reforms, pushing postmarket surveillance to the top of its agenda.


Related Content

New UK Market Surveillance Levy Could Cost Medtech Companies Millions Each Year
In Case You Missed It: Top 10 Gray Sheet Stories In February
In Case You Missed It: Top 10 "Gray Sheet" Stories In January
EU Policy-Makers Set End-Of-Year Goal To Finalize Device, Dx Reform
EU Device Reform Proposal Adds More Government Scrutiny, But No FDA-Like Review Body





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts